FI771763A - Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. - Google Patents

Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan.

Info

Publication number
FI771763A
FI771763A FI771763A FI771763A FI771763A FI 771763 A FI771763 A FI 771763A FI 771763 A FI771763 A FI 771763A FI 771763 A FI771763 A FI 771763A FI 771763 A FI771763 A FI 771763A
Authority
FI
Finland
Prior art keywords
disubstituerad
blodkroppar
foerhindrande
verkan
hydantoin
Prior art date
Application number
FI771763A
Other languages
English (en)
Other versions
FI71930C (fi
FI71930B (fi
Inventor
Albert Gordon Caldwell
Norman Whittaker
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI771763A publication Critical patent/FI771763A/fi
Application granted granted Critical
Publication of FI71930B publication Critical patent/FI71930B/fi
Publication of FI71930C publication Critical patent/FI71930C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI771763A 1976-06-03 1977-06-02 Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan. FI71930C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB2287776 1976-06-03
GB2287776 1976-06-03
GB5034076 1976-12-02
GB5034076 1976-12-02
GB1214577 1977-03-23
GB1214577 1977-03-23

Publications (3)

Publication Number Publication Date
FI771763A true FI771763A (fi) 1977-12-04
FI71930B FI71930B (fi) 1986-11-28
FI71930C FI71930C (fi) 1987-03-09

Family

ID=27256793

Family Applications (1)

Application Number Title Priority Date Filing Date
FI771763A FI71930C (fi) 1976-06-03 1977-06-02 Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan.

Country Status (12)

Country Link
JP (1) JPS52151168A (fi)
CA (1) CA1176261A (fi)
CH (3) CH645631A5 (fi)
DE (1) DE2724948A1 (fi)
DK (1) DK244577A (fi)
ES (5) ES459412A1 (fi)
FI (1) FI71930C (fi)
FR (1) FR2362839A1 (fi)
HU (1) HU183046B (fi)
NL (1) NL7706064A (fi)
NZ (1) NZ184281A (fi)
SE (2) SE446336B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
JPS5463083A (en) * 1977-09-05 1979-05-21 Wellcome Found Organism active nitrogen compound
JPS5492962A (en) * 1977-12-01 1979-07-23 Wellcome Found Thiohydantoin compound
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (en) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
GB1599740A (en) * 1978-05-31 1981-10-07 Wellcome Found Hydantoin derivatives
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
US4294972A (en) * 1978-06-15 1981-10-13 Beecham Group Limited 1,2-Disubstituted oxo triazolidine
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
GB2050371A (en) * 1979-05-09 1981-01-07 Wellcome Found Optically active hydantoin derivatives and pharmaceutical formulations containing them
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (ja) * 1995-08-18 1996-04-02 有限会社春江加工 ミニディスク用ケース
PL370515A1 (en) 2001-11-30 2005-05-30 Eli Lilly And Company Peroxisome proliferator activated receptor agonists
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
WO2004108215A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin e analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
HU183046B (en) 1984-04-28
CA1176261A (en) 1984-10-16
DE2724948A1 (de) 1977-12-15
SE8203161L (sv) 1982-05-19
ES482010A1 (es) 1980-08-16
NL7706064A (nl) 1977-12-06
CH645631A5 (en) 1984-10-15
CH646426A5 (en) 1984-11-30
JPS6222986B2 (fi) 1987-05-20
CH647511A5 (en) 1985-01-31
JPS52151168A (en) 1977-12-15
ES478156A1 (es) 1979-11-01
FR2362839A1 (fr) 1978-03-24
FI71930C (fi) 1987-03-09
FI71930B (fi) 1986-11-28
DK244577A (da) 1977-12-04
SE7706428L (sv) 1977-12-04
NZ184281A (en) 1980-04-28
ES459412A1 (es) 1978-11-01
ES8103057A1 (es) 1981-02-16
ES470428A1 (es) 1979-09-01
FR2362839B1 (fi) 1980-02-01
SE446336B (sv) 1986-09-01
ES489883A0 (es) 1981-02-16

Similar Documents

Publication Publication Date Title
ES220945Y (es) Bolsa.
FI771763A (fi) Foerfarande foer framstaellning av 1,5-disubstituerad hydantoin med aggregation av blodkroppar foerhindrande verkan.
NL7705037A (nl) M-fenoxybenzamide-derivaten.
NL7703919A (nl) Zaaimachine.
NL7613335A (nl) Voedingstoediening.
BE856409A (fr) 2,6-methano-2h-1-benzoxocines
NL7607985A (nl) 12-alkoxy-3,7,11-trimethyldodecatetraenen.
NL7707558A (nl) Fenothiazinederivaten.
BE854184A (fr) 1,2,6-thiadiazinones
FI773466A (fi) Substituerade 2,1,3-bentsotiadiazinfoereningar
NL7610150A (nl) 1,5-dihydro-2h-1,4-benzodiazepin-2-on derivaten.
NL7713806A (nl) Beker.
NL7708845A (nl) 1-aryloxy-3-aminopropan-2-ol derivaten.
NL7613336A (nl) Voedingstoediening.
NL7713324A (nl) 1-cycloalkylcarbonyl-3-(3,5-dihalogeenfenyl)imi- dazolidine-2,4-dionen.
IT1086066B (it) 1,3-diossani erbicidi
IT1077596B (it) 1,3-diidro-1'-dimetilfosfinilalchil-3-fenilspiro isobenzofurani
NL7708338A (nl) Acetidinederivaten.
BE851751A (fr) 5,6-deshydropenicillines
FI773722A (fi) Reducering av 2,5-diketoglukonsyra
BE864950A (fr) 2,6-methano-3-benzazocines
NL7701864A (nl) Gesubstitueerde chinolinederivaten.
DK462377A (da) 1-(3,3,3-triarylpropyl)-4-phenyl-4-piperidinomethanolethere
NL7707551A (nl) 2,5-dichloor-4-broomfenylazo-4-chloorfenyl- sulfide.
FI834519A0 (fi) Mellanprodukt foer framstaellning av 1-fenyl-2,3,4,5-tetrahydro-1h-3-bensazepinfoereningar

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: THE WELLCOME FOUNDATION LIMITED